MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    FDG-PET degeneration patterns predict amyloid deposition in Corticobasal Syndrome

    J. Parmera, A. Coutinho, A. Neto, C. Ono, M. Aranha, C. Buchpiguel, R. Nitrini, E. Barbosa, S. Brucki (Sao Paulo, Brazil)

    Objective: To investigate if an individual clinically-focused analysis of brain FDG-PET metabolic patterns and a comprehensive neurological evaluation could distinguish Corticobasal Syndrome (CBS) pathological variants…
  • MDS Virtual Congress 2020

    Potential Diagnosis Biomarks in Serum Biochemical items of Vascular Parkinsonism Patients

    Y. Li, YY. Gao, K. Nie, L.J Wang (Guangzhou, China)

    Objective: Evaluating the serum biochemical items for diagnosis of vascular parkinsonism. Background: Currently, the most effective diagnostic methods for VP are mainly based on clinical symptoms.…
  • MDS Virtual Congress 2020

    Circadian rhythm alterations in an in vitro cellular model of Spinocerebellar ataxia type 17

    F. Motolese, A. Casamassa, A. Vescovi, V. Di Lazzaro, J. Rosati, M. Marano (Rome, Italy)

    Objective: To study in vitro expression of circadian rhythm genes (CLOCK, BMAL) in fibroblasts and neural cells of SCA17 patients. Background: Spinocerebellar Ataxia 17 (SCA17)…
  • MDS Virtual Congress 2020

    Does “5-2-1” identify patients with suspected Advanced Parkinson’s Disease? Evidence of clinical accuracy from G7 countries

    A. Antonini, P. Odin, T. Henriksen, M. Soileau, R. Rodriguez-Cruz, A. Alobaidi, Y. Jalundhwala, P. Kandukuri, J.C Parra, K. Onuk, P. Kukreja, A. Gillespie, J. Pike, K.R Chaudhuri (North Chicago, IL, USA)

    Objective: Evaluate the psychometric properties of (i) the “5-2-1” criteria and (ii) consensus-driven clinical indicators of suspected advanced Parkinson’s disease (APD). Background: Recent consensus panel…
  • MDS Virtual Congress 2020

    Speech biometrics can predict cerebellar dysfunction in multiple sclerosis

    A. Vogel, G. Noffs, F. Boonstra, T. Perera, S. Kolbe, J. Stankovich, H. Butzkueven, A. Evans, A. der Walt (Melbourne, Australia)

    Objective: To objectively describe cerebellar mediated speech function using a multiparameter index that reflects pathology and quality of life in MS. Background: Cerebellar function plays…
  • MDS Virtual Congress 2020

    Allied health interventions for freezing of gait in Parkinson’s disease: a protocol for a systematic review and meta-analyses

    L. Goh, N. Allen, J. Song, L. Clemson, C. Canning (Lidcombe, Australia)

    Objective: The primary aim is to determine whether allied health interventions reduce freezing of gait (FOG) in people with Parkinson’s disease (PD) in the short-term…
  • MDS Virtual Congress 2020

    Respiratory training in Parkinson’s disease: a systematic review

    M. Nijkrake, V. van Dongen, P. Wees, B. Bloem, H. Kalf (Nijmegen, Netherlands)

    Objective: This systematic review provides an overview investigating the effects of different respiratory training interventions in Parkinson’s disease (PD). Background: Signs of respiratory dysfunction are…
  • MDS Virtual Congress 2020

    Nutrient patterns in Parkinson’s disease: A case-control study

    S. Diaconu, A. Maceasa, B. Ciopleias, R. Zosin, C. Falup-Pecurariu (Braşov, Romania)

    Objective: The aim of this study is to evaluate dietary habits and food preferences of PD patients versus healthy controls. Background: Currently, there is a…
  • MDS Virtual Congress 2020

    Wilson and Parkinson’s Disease: Beyond Copper Metabolism

    B. Baena Álvarez, R. Sainz Amo, F. Rodríguez Jorge, J. Masjuán Vallejo, J.C Martínez Castillo, A. Celdrán, J. Vaamonde Gamo, J.P Cabello, D. Burgos Santamaría, G. Sánchez Díez, I. Parées Moreno, G. Garcia-Ribas, A. Alonso Cánovas (Madrid, Spain)

    Objective: To show an unusual presentation of Wilson´s disease. Background: Parkinsonism is evident in approximately 40% of patients with Wilson’s disease and responds favourably to…
  • MDS Virtual Congress 2020

    Loss‐of‐function mutations in NR4A2 cause dopa‐responsive dystonia-parkinsonism

    T. Wirth, LL. Mariani, G. Bergant, M. Baulac, M.O Habert, N. Drouot, E. Ollivier, A. Hodžic, G.o Rudolf, P. Nitschke, G.a Rudolf, J. Chelly, C. Tranchant, M. Anheim, E. Roze (London, United Kingdom)

    Objective: To report two patients with early-onset dystonia-parkinsonism as a result of loss-of-function mutations in nuclear receptor subfamily 4 group A member 2 (NR4A2). Background:…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley